IP Library Granted Patent US 7,173,130
Granted Patent B2
US 7,173,130 · App. 09/967,772 · Granted Feb 6, 2007

Detection of transmembrane potentials by optical methods

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,173,130
App. No.
09/967,772
Granted
Feb 6, 2007
Kind
B2
Abstract

Methods and compositions are provided for detecting changes in membrane potential in membranes biological systems. In one aspect, the method comprises; a) providing a living cell with a first reagent comprising a charged hydrophobic molecule which is typically a fluorescence resonance energy transfer (FRET) acceptor or donor, or is a quencher and is capable of redistributing within the membrane of a biological membrane in response to changes in the potential across the membrane; b) providing the cell with a second reagent that can label the first face or the second face of a biological membrane within the cell; c) detecting light emission from the first reagent or the second reagent. One aspect of this method involves monitoring membrane potential changes in subcellular organelle membranes in a living cells. Another aspect of the invention is the use of certain embodiments of the method for the screening of test chemicals for activity to modulate the activity of a target ion channel. Another aspect of the present invention is a transgenic organism comprising a first reagent that comprises a charged hydrophobic fluorescent molecule, and a second reagent comprising a bioluminescent or naturally fluorescent protein.

Claims (30)

1. A compound having the formula

wherein

X is oxygen or sulfur;

R is independently selected from H, aryl, aralkyl, heteroalkyl, cycloalkyl, cycloalkyl lower-alkyl, and C 7 –C 12 alkyl

n is an integer from 1 to 3;

and salts thereof.

2. The compound of claim 1 , wherein X is sulfur.

3. The compound of claim 1 , wherein the aryl group is substituted with a substituent selected from a hydrocarbyl, an alkyl, a heteroalkyl, and a halogen group.

4. The composition of claim 1 , wherein R is heteroalkyl.

5. The composition of claim 4 wherein the heteroalkyl has the formula:

—(CH 2 ) x A(CH 2 ) z CH 3 ,

wherein:

A is oxygen or sulfur;

x is independently an integer from 1 to about 20;

z is independently an integer from 1 to about 20; and

x+1+z is less than about 40.

6. A compound having the formula

wherein

X is oxygen or sulfur;

R is independently selected from H and heteroalkyl,

n is an integer from 1 to 3;

and salts thereof.

7. The compound of claim 6 , wherein X is sulfur.

8. The compound of claim 6 , wherein the heteroalkyl group has a formula:

—(CH 2 ) x A(CH 2 ) z CH 3 ,

wherein:

A is oxygen or sulfur;

x is independently an integer from 1 to about 20;

z is independently an integer from 1 to about 20; and

x+1+z is less than about 40.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 20, 2011
From: UNIVERSITY OF CALIFORNIA, SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025666/0482 →
Continuity (4)
Continuation 0945995600 · Dec 13, 1999
Continuation In Part 0876586000
Continuation In Part 0848197700 · Jun 6, 1995
Related Publication 20020164577A1 · Nov 7, 2002